ZLD 0.00% 69.0¢ zelira therapeutics limited

Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-147

  1. 107 Posts.
    lightbulb Created with Sketch. 7
    The market is $12bn - $13bn if you include the other drugs on the market competing with Lyrica, and growing at 6% each year.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.